Market Size of Nephrostomy Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Nephrostomy Devices Market Analysis
The nephrostomy devices market is expected to register a CAGR of 7.8% during the forecast period.
- COVID-19 significantly impacted the nephrostomy devices market during the initial wave since many of the nephrology-related surgeries and consultations were delayed due to the global lockdown. For instance, as per the article published in December 2021 in PubMed, the COVID-19 epidemic pushed urology departments around the world to restructure care due to inadequate resources and personnel. Hence, the nephrostomy devices market was impacted by the pandemic. However, as the restrictions are relaxed, the market is expected to witness growth in the coming years due to the increase in kidney diseases and the rise in the adoption of nephrostomy devices.
- Factors such as an increase in kidney diseases, a rise in demand for minimally invasive surgeries, and technological advances in nephrostomy devices are expected to drive market growth over the forecast period. For instance, as per the American Cancer Society 2023 cancer statistics, about 81,800 new cases of kidney cancer are estimated to be diagnosed in the United States in 2023. This figure was an increase from 79,000 cases in 2022.
- Hence, the high prevalence of kidney diseases is likely to increase the demand for nephrostomy devices since people with cancer may need a nephrostomy if there is a blockage in the urinary system, thereby driving market growth over the forecast period. The demand for minimally invasive surgeries(MIS) is also one of the major factors driving the market growth over the forecast period. For instance, as per the article published in September 2022 in JAMA Network, compared with open surgery, minimally invasive surgery has been found to have a shorter length of hospital stay, reduced blood loss, lower rates of postoperative morbidity, reduced operative pain, improved cosmesis, and equivalent oncological outcomes. Hence, considering the advantages offered by MIS in nephrostomy, the demand for Nephrostomy devices is likely to increase over the forecast period.
- Hence, increasing cases of kidney diseases, and rise in demand for minimally invasive surgical procedures, and increased awareness about the product are the key driving factors in the nephrostomy devices market. However, the rise in alternative procedures and risks associated with nephrostomy is expected to restrain the market growth over the forecast period.
Nephrostomy Devices Industry Segmentation
As per the scope of the report, nephrostomy devices are used to create an artificial opening between the kidney and the skin, allowing for the urinary diversion directly from the upper part of the urinary system (renal pelvis).
The nephrostomy devices market is segmented by product type (drainage tubes, dilator sheaths, guidewires, nephrostomy catheters, and other products) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The report also covers the estimated market sizes and trends for 17 countries across major global regions.
The report offers the value (USD million) for the above segments.
| By Product Type | |
| Drainage Tubes | |
| Dilators Sheaths | |
| Guidewires | |
| Nephrostomy Catheters | |
| Other Product Types |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Nephrostomy Devices Market Size Summary
The nephrostomy devices market is poised for significant growth, driven by an increasing prevalence of kidney diseases and a rising demand for minimally invasive surgical procedures. The market experienced initial setbacks due to the COVID-19 pandemic, which delayed nephrology-related surgeries and consultations. However, as restrictions have eased, the market is expected to recover and expand, supported by technological advancements in nephrostomy devices. The demand for these devices is further bolstered by the high incidence of kidney cancer and other related conditions, which often necessitate nephrostomy procedures to address urinary system blockages. The preference for minimally invasive surgeries, known for their benefits such as shorter hospital stays and reduced postoperative complications, is also a key factor propelling market growth.
North America is anticipated to hold a significant share of the nephrostomy devices market, attributed to the region's high incidence of kidney diseases, increased healthcare expenditure, and the availability of skilled medical professionals. The prevalence of kidney stones and other related conditions in North America underscores the demand for nephrostomy devices. The market is characterized by fragmentation, with several major players like Boston Scientific Corporation, Teleflex Incorporated, and Becton, Dickinson and Company leading the charge. Ongoing research and development, along with clinical studies aimed at optimizing nephrostomy procedures, are expected to further enhance market dynamics. Despite the promising growth prospects, the market faces challenges from alternative procedures and associated risks, which could potentially restrain its expansion.
Nephrostomy Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 High Prevalence of Kidney Diseases
-
1.2.2 Increasing Popularity of Minimally Invasive Surgeries and Technological Advancements in Nephrostomy
-
-
1.3 Market Restraints
-
1.3.1 Rise in Alternative Procedures Such as Ureteral Stenting
-
1.3.2 Risk Associated with Nephrostomy Procedure
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Product Type
-
2.1.1 Drainage Tubes
-
2.1.2 Dilators Sheaths
-
2.1.3 Guidewires
-
2.1.4 Nephrostomy Catheters
-
2.1.5 Other Product Types
-
-
2.2 Geography
-
2.2.1 North America
-
2.2.1.1 United States
-
2.2.1.2 Canada
-
2.2.1.3 Mexico
-
-
2.2.2 Europe
-
2.2.2.1 Germany
-
2.2.2.2 United Kingdom
-
2.2.2.3 France
-
2.2.2.4 Italy
-
2.2.2.5 Spain
-
2.2.2.6 Rest of Europe
-
-
2.2.3 Asia-Pacific
-
2.2.3.1 China
-
2.2.3.2 Japan
-
2.2.3.3 India
-
2.2.3.4 Australia
-
2.2.3.5 South Korea
-
2.2.3.6 Rest of Asia-Pacific
-
-
2.2.4 Middle East and Africa
-
2.2.4.1 GCC
-
2.2.4.2 South Africa
-
2.2.4.3 Rest of Middle East and Africa
-
-
2.2.5 South America
-
2.2.5.1 Brazil
-
2.2.5.2 Argentina
-
2.2.5.3 Rest of South America
-
-
-
Nephrostomy Devices Market Size FAQs
What is the current Nephrostomy Devices Market size?
The Nephrostomy Devices Market is projected to register a CAGR of 7.80% during the forecast period (2024-2029)
Who are the key players in Nephrostomy Devices Market?
Boston Scientific Corporation, Teleflex Incorporated, Cardinal Health, Becton, Dickinson and Company and B. Braun SE are the major companies operating in the Nephrostomy Devices Market.
